Database ITANET - ENETS Registry
-
- STATUS
- Recruiting
-
- participants needed
- 3600
-
- sponsor
- Italian Association Neuroendocrine Tumors
Summary
This is a prospective observational study with the aim to create an Italian database for the collection of data on diagnostic approach, therapy and follow up of patients affected by GEP-NET (gastro-enteric-pancreatic neuroendocrine tumours) and to include these data into a multi-national European registry database, adhering to the ENETS (european neuroendocrine tumor society)-registry project.
Description
Each participating site will have access through the reserved area of webpage www.ita-net.org, where a proper link is enabled for the data recording in a database which ENETS set-up for the participating Sites in Europe, the ENETS-registry (https://www.enets-registry.eu/enets/).
The eligible patients, visited at each participating site, will be asked to adhere to the ENETS-project through a proper Informed Consent obtainment procedure.
The data will be collected in an anonymised way. Each patient will be identified by a code.
The data management and quality check of the Italian data is deputed to ITANET. The data will be collected in a prospective way, both for the new diagnoses (first visits) and for the follow up visits of patients with already acquired diagnosis. The enrolment will take place during the outpatient visit or at the time of the hospitalisation for the NET-related surgery.
Of course, considering the observational nature of the study, the follow up visits will be planned on the basis of each patient's clinical need, which is different patient by patient, according to the disease staging, the primary tumour location, the eventual surgery.
The data flow will be the following:
- The participating site records the data in the database, waiting to be validated;
- ITANET has the role to check the recorded data for completeness and coherence in order
to decide whether:
- The data are acceptable: in this case the validated data will be acquired from ENETS-registry;
- There are discrepancies: in this case a query will be sent to the related site in order to check, correct/explain where applicable and to resubmit the data. The process starts again until final validation.
The data will be collected yearly to provide several information, such as:
- Type of NETs followed by the reference national sites for the management of the study pathology;
- Tools used for the diagnosis definition and the disease staging;
- Therapeutic approach (surgical or medical);
- Disease trend during follow up.
Details
| Condition | Gastro-entero Pancreatic Neuroendocrine Tumors |
|---|---|
| Age | 19years - 100years |
| Clinical Study Identifier | NCT04282083 |
| Sponsor | Italian Association Neuroendocrine Tumors |
| Last Modified on | 19 February 2024 |
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.